H

HK Inno.N Corp
KOSDAQ:195940

Watchlist Manager
HK Inno.N Corp
KOSDAQ:195940
Watchlist
Price: 57 000 KRW 4.59% Market Closed
Market Cap: ₩1.6T

Net Margin

6.7%
Current
Improving
by 0.9%
vs 3-y average of 5.8%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.7%
=
Net Income
₩67.2B
/
Revenue
₩1T

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
6.7%
=
Net Income
₩67.2B
/
Revenue
₩1T

Peer Comparison

Country Company Market Cap Net
Margin
KR
HK Inno.N Corp
KOSDAQ:195940
1.5T KRW
Loading...
US
Eli Lilly and Co
NYSE:LLY
969.6B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.3B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
271.3B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
148.3B USD
Loading...
FR
Sanofi SA
PAR:SAN
93.8B EUR
Loading...

Market Distribution

Higher than 73% of companies in Korea
Percentile
73nd
Based on 2 632 companies
73nd percentile
6.7%
Low
-168 471.3% — -2.9%
Typical Range
-2.9% — 5.8%
High
5.8% — 21 012.5%
Distribution Statistics
Korea
Min -168 471.3%
30th Percentile -2.9%
Median 1.9%
70th Percentile 5.8%
Max 21 012.5%

HK Inno.N Corp
Glance View

Market Cap
1.6T KRW
Industry
Pharmaceuticals

HK inno.N Corp. engages in the provision of healthcare services. The company is headquartered in Chungju, Chungcheongbuk-Do. The company went IPO on 2021-08-09. The firm operates its business through three segments. The Prescription Drug segment is engaged in the manufacture and sale of hormone drugs, anticancer drugs, high blood pressure drugs, gastroesophageal reflux disease drugs, blood nutrient supplies, the circulatory system and others. The Health Beauty and Beverage (HB&B) segment is engaged in the manufacture and sale of products such as hangover relieving products, as well as health drinks and food products. The Other segment is engaged in the trademark royalties business and other services. The firm sells its products within domestic market and to overseas markets.

Intrinsic Value
57 689.66 KRW
Undervaluation 1%
Intrinsic Value
Price
H
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
6.7%
=
Net Income
₩67.2B
/
Revenue
₩1T
What is HK Inno.N Corp's current Net Margin?

The current Net Margin for HK Inno.N Corp is 6.7%, which is above its 3-year median of 5.8%.

How has Net Margin changed over time?

Over the last 3 years, HK Inno.N Corp’s Net Margin has increased from 5.3% to 6.7%. During this period, it reached a low of 4% on Mar 31, 2023 and a high of 7.4% on Mar 31, 2025.

Back to Top